Search results
Showing 31 to 45 of 99 results for melanoma
This guideline covers how to communicate the risks and benefits of natural sunlight exposure (specifically, the ultraviolet rays UVA and UVB) to help people understand why they may need to modify their behaviour to reduce their risk of skin cancer and vitamin D deficiency.
Evidence-based recommendations on photodynamic therapy for non-melanoma skin tumours (including premalignant and primary non-metastatic skin lesions). This involves applying (or sometimes injecting) a photosensitising agent and using light to activate it, destroying the tumour cells.
View recommendations for IPG155Show all sections
Sections for IPG155
This guideline covers identifying children, young people and adults with symptoms that could be caused by cancer. It outlines appropriate investigations in primary care, and selection of people to refer for a specialist opinion. It aims to help people understand what to expect if they have symptoms that may suggest cancer.
Show all sections
Sections for NG12
This guideline covers assessing and managing psoriasis in adults, young people and children. It aims to improve long-term disease control and quality of life for people with psoriasis.
View recommendations for CG153Show all sections
Histological margins: What is the optimal histological excision margin in stage 0 melanoma?
Histological margins: What is the optimal histological excision margin in stage 0 melanoma? Any explanatory notes(if applicable) For a...
Metastatic malignant disease of unknown primary origin in adults: diagnosis and management (CG104)
This guideline covers diagnosing and managing secondary cancer in people aged 18 and over when the site of the primary cancer is unknown. This includes people who have had treatment for cancer before. It aims to improve quality of life by offering advice on tests for identifying the site of the primary cancer and options for managing the person’s condition.
effectiveness of localised treatment for people with stages III and IV melanoma? Any explanatory notes(if applicable) For a short...
be used for risk stratification and treatment planning for people with melanoma? Any explanatory notes(if applicable) For a short...
effect of drug therapy for concurrent conditions on melanoma survival: In people diagnosed with melanoma what is the effect...
In development [GID-TAG509] Expected publication date: 28 September 2016
are the experiences of people who are living with, through and beyond a melanoma diagnosis in terms of survivorship and their disease...
which imaging modality should be used for people with stage IIB to IIIC melanoma? Any explanatory notes(if applicable) For a short...
Evidence-based recommendations on melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver. This involves diverting the blood flow from the liver to the rest of the body while the drug is delivered directly into the liver.
View recommendations for IPG691Show all sections
vemurafenib and ipilimumab in patients who have BRAF V600 mutation-positive melanoma. Any explanatory notes(if applicable) This may...
Question Vitamin D supplementation: In people with stage I to III melanoma does vitamin D supplementation improve overall survival? This...